BLATAM

Blatam is a specialized Contract Research Organization (CRO) providing end-to-end clinical trial management and regulatory services throughout Latin America. Headquartered in Argentina, the company supports pharmaceutical, biotechnology, and medical device sponsors in navigating the regional regulatory landscape and executing Phase I-IV clinical studies. Their core competencies include site feasibility, patient recruitment, clinical monitoring, and pharmacovigilance across major markets such as Brazil, Mexico, and Colombia. Blatam leverages local expertise to accelerate drug development timelines and ensure compliance with international quality standards. The company acts as a strategic partner for international firms seeking to access the diverse patient populations and high-quality medical infrastructure available in the region. Their services are designed to streamline the clinical development process while maintaining rigorous adherence to ICH-GCP guidelines.